Monthly injection with tezepelumab helped 90% of patients with severe asthma reduce intake of daily steroid tablets. The ...

Objective Systemic corticosteroids for 5–7 days are standard care for asthma exacerbations, but the optimal duration and ...

Tezepelumab reduced exacerbations across all seasons in severe uncontrolled asthma, even among patients with perennial and seasonal allergies.

They found that an injected antibody called tezepelumab allowed 90% of people with severe asthma to reduce their use of daily ...

A new trial at Sheffield Children's Hospital will test whether a combined inhaler can better control asthma symptoms and ...

A new injection, tezepelumab, could help severe asthma patients to stop oral steroids safely. It could reduce steroid-related ...

A large clinical trial published in The Lancet Respiratory Medicine has found that a monthly injection of tezepelumab may ...

(Alliance News) - A monthly injection could help people with severe asthma come off daily steroid tablets entirely without any impact on symptoms, a trial has found. Tezepelumab – also known as ...

A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with ...

Daily steroid pills are often necessary for severe cases of asthma, but they raise the risk of several serious conditions.

A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with ...

Investing.com -- Nektar Therapeutics (NASDAQ:NKTR) stock rose 3.6% on Monday after the company presented new data showing its experimental drug rezpegaldesleukin improved asthma symptoms in patients ...